58 results
8-K
EX-10.1
PYXS
Pyxis Oncology Inc
28 Feb 24
Pyxis Oncology Announces $50 Million Private Placement
7:02am
. There is no action, suit, proceeding, arbitration, claim, investigation or inquiry pending or, to the Company’s knowledge, threatened against … . As of the date hereof, there is no suit, action, proceeding or investigation pending or, to the knowledge of the Company, threatened against the Company
8-K
EX-10.2
y87 kbniv
28 Feb 24
Pyxis Oncology Announces $50 Million Private Placement
7:02am
8-K
EX-4.1
kjtxmgtor
28 Feb 24
Pyxis Oncology Announces $50 Million Private Placement
7:02am
8-K
EX-10.1
da5f0o08f4h6plcj68
28 Nov 23
Pyxis Oncology Announces Appointment of Ken Kobayashi, M.D., F.A.C.P as Chief Medical Officer
7:22am
S-8 POS
EX-5.1
g5yqr794 9h
23 Aug 23
Registration of securities for employees (post-effective amendment)
5:30pm
POS AM
EX-5.1
1jx m432md
23 Aug 23
Prospectus update (post-effective amendment)
5:28pm
S-8
EX-5.1
49pgdfmufze5516zhq48
23 Aug 23
Registration of securities for employees
5:28pm
424B3
u9nkz5biwso1gfihk94z
30 Jun 23
Prospectus supplement
4:05pm
S-4/A
EX-5.1
25o9hqmu08 16byy
29 Jun 23
Registration of securities issued in business combination transactions (amended)
4:09pm
S-4/A
3a5 fdk8j4tkm
29 Jun 23
Registration of securities issued in business combination transactions (amended)
4:09pm
S-4
kgn douma8
8 Jun 23
Registration of securities issued in business combination transactions
8:03am
425
i7ybfsv0rr8zki0dhkml
24 May 23
Business combination disclosure
7:05am
425
4oj 82hxn
24 May 23
Business combination disclosure
7:03am
8-K
EX-10.1
9lq0nxnd
24 May 23
Pyxis Oncology to Acquire Apexigen
6:59am